Evidence map›Paper›PMID 42809865›Full record

ArticleTechnology in cancer research & treatment

Preparation and In Vitro Evaluation of the DOX@Mem-HMnO2 Bioinspired Nanosystem: A Proof-of-Concept Study.

Jiangang Chen, Ao Xu, Yusheng Tang, Zhen Yang, Shibo Gao, Yan Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiangang ChenPostgraduate Training Base at Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, China.
Ao XuPostgraduate Training Base at Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, China.
Yusheng TangPostgraduate Training Base at Shanghai Gongli Hospital, Ningxia Medical University, Shanghai, China.
Zhen YangSchool of Medical Technology, Gongli Hospital, Shanghai University of Technology, Shanghai, China.
Shibo GaoSchool of Medical Technology, Gongli Hospital, Shanghai University of Technology, Shanghai, China.
Yan ZhangDepartment of Orthopedics, Gongli Hospital Pudong New Area, Shanghai, China.ORCID 0000-0001-8903-7966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IntroductionCell membrane-coated nanoparticles are emerging as promising biomimetic platforms for targeted cancer drug delivery, owing to their homotypic tumor-targeting ability and favorable biocompatibility. In this study, we fabricated a biomimetic DOX@Mem-HMnO

Indexed as

DoxorubicinDrug CarriersLung NeoplasmsManganese CompoundsNanoparticlesOxidesA549 CellsBiomimetic MaterialsCell MembraneCell ProliferationDrug Delivery SystemsHumansProof of Concept StudyDoxorubicinDrug CarriersManganese Compoundsmanganese dioxideOxidesA549 lung adenocarcinomabiomimetic nanosystemcell-membrane-coated nanoparticlesdoxorubicinhollow mesoporous manganese dioxide

Identifiers

PMID42809865
PMCPMC13735642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.